Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Bloom

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|September 22, 1973
Anti-lymphocyte globulin and factor-VIII-related antigenI R Peake, A L Bloom, S A Shearn, et al.
Thrombosis Research|January 1, 1979
High potency factor VIII concentrate: more effective than cryoprecipitate in a patient with von Willebrand's disease and inhibitorA L Bloom, I R Peake, R A Furlong, et al.
British Journal of Haematology|June 1, 1989
Defective propeptide processing and abnormal activation underlie the molecular pathology of factor IX Troed-y-RhiwM B Liddell, D P Lillicrap, I R Peake, et al.
Lancet (London, England)|September 22, 1979
Prenatal diagnosis of severe von Willebrand's diseaseC H Rodeck, R S Mibashan, I R Peake, et al.
Clinical and Laboratory Haematology|January 1, 1983
Human factor IX inhibitors: immunochemical characteristics and treatment with activated concentrateJ C Giddings, A L Bloom, M A Kelly, et al.
British Journal of Haematology|June 1, 1979
An immunoradiometric assay for procoagulant factor VIII antigen: results in haemophilia, von Willebrand's disease and fetal plasma and serumI R Peake, A L Bloom, J C Giddings, et al.
Journal of Medical Genetics|November 1, 1988
Carrier detection through the use of abnormal deletion junction fragments in a case of haemophilia B involving complete deletion of the factor IX geneR J Matthews, I R Peake, A L Bloom, et al.
British Journal of Haematology|February 1, 1985
Immunoassays of factor IX antigen using monoclonal antibodiesA Yoshioka, J C Giddings, J E Thomas, et al.
The British Journal of Surgery|March 1, 1975
Postoperative problems and management after hepatic resection for blunt injury to the liverT Vajrabukka, A L Bloom, M Sussmann, et al.
Thrombosis and Haemostasis|April 23, 1979
Factor VIII inhibitor and bronchogenic carcinomaS A Al-Ismail, D H Parry, C U Moisey, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|September 22, 1973
Anti-lymphocyte globulin and factor-VIII-related antigenI R Peake, A L Bloom, S A Shearn, et al.
Thrombosis Research|January 1, 1979
High potency factor VIII concentrate: more effective than cryoprecipitate in a patient with von Willebrand's disease and inhibitorA L Bloom, I R Peake, R A Furlong, et al.
British Journal of Haematology|June 1, 1989
Defective propeptide processing and abnormal activation underlie the molecular pathology of factor IX Troed-y-RhiwM B Liddell, D P Lillicrap, I R Peake, et al.
Lancet (London, England)|September 22, 1979
Prenatal diagnosis of severe von Willebrand's diseaseC H Rodeck, R S Mibashan, I R Peake, et al.
Clinical and Laboratory Haematology|January 1, 1983
Human factor IX inhibitors: immunochemical characteristics and treatment with activated concentrateJ C Giddings, A L Bloom, M A Kelly, et al.
British Journal of Haematology|June 1, 1979
An immunoradiometric assay for procoagulant factor VIII antigen: results in haemophilia, von Willebrand's disease and fetal plasma and serumI R Peake, A L Bloom, J C Giddings, et al.
Journal of Medical Genetics|November 1, 1988
Carrier detection through the use of abnormal deletion junction fragments in a case of haemophilia B involving complete deletion of the factor IX geneR J Matthews, I R Peake, A L Bloom, et al.
British Journal of Haematology|February 1, 1985
Immunoassays of factor IX antigen using monoclonal antibodiesA Yoshioka, J C Giddings, J E Thomas, et al.
The British Journal of Surgery|March 1, 1975
Postoperative problems and management after hepatic resection for blunt injury to the liverT Vajrabukka, A L Bloom, M Sussmann, et al.
Thrombosis and Haemostasis|April 23, 1979
Factor VIII inhibitor and bronchogenic carcinomaS A Al-Ismail, D H Parry, C U Moisey, et al.
Pageof 14